Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression

Clinical trial NCT03027362 · COMPLETED

Trial details

NCT number: NCT03027362
Sponsor: Yale University
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2017-01-01
Primary completion: 2019-09-30
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.